Activated granzyme B (GzmB)-expressing CD8+, CD4+ TEM and CD4+ Treg cells were also abundant (91%, 37% and 27%, respectively) in the posttreatment tumor (Fig. 2d). The gene discussed is CD8A; the disease is neoplasm.